What Changed
- Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
- NYSE flags Accendra Health (NYSE: ACH) for noncompliance, but no immediate delisting follows.
- Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
Price Move History
- Daily moves over 5%
- 67 209 sessions, January 2, 2026 to October 30, 2026
- Largest daily move
- -50% close of August 10, 2026
- 1-month change
- -54.8% closing prices, September 30, 2026 to October 30, 2026
Company Description
Accendra Health, Inc. (NYSE: ACH) is described as a nationwide provider of products, technology and services that support health beyond the hospital for millions of people each year. According to the company, it connects patients, providers and insurers, with a focus on people living with chronic and complex health conditions. The company’s shares trade on the New York Stock Exchange under the ticker symbol ACH.
Accendra Health states that it is backed by the expertise of its Apria and Byram brands and that it is focused on reimagining the future of home-based care. Within this context, the company highlights a portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology and ostomy. These offerings are positioned as part of its effort to promote better health outcomes and improve quality of life outside of traditional hospital settings.
The company operates in the wholesale-medical, dental and hospital equipment and supplies sector. Its stated role is to support care delivery beyond the hospital, which includes coordination among patients, healthcare providers and insurers. The emphasis on chronic and complex health conditions suggests that its products and services are intended to support ongoing, long-term care needs in home and community environments.
Accendra Health has also communicated a significant corporate transition. It announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand on December 31, 2025. Following this transaction, the company’s common stock began trading on the New York Stock Exchange under the new ticker symbol ACH. This marks a shift from its prior identity referenced in historical descriptions as Owens & Minor, Inc., a healthcare solutions company.
According to the company’s description, its approach combines products, technology and services to support health beyond the hospital. The focus on home-based care and chronic conditions frames its role within the broader healthcare ecosystem, particularly in areas such as diabetes management, sleep health, wound care, respiratory care, urology and ostomy support.
Business focus and offerings
Accendra Health describes its business as centered on supporting health beyond the hospital. It states that it provides products, technology and services that are used by patients with chronic and complex health conditions. The company’s description highlights several categories of essentials, including:
- Diabetes
- Sleep health
- Wound care
- Respiratory care
- Urology
- Ostomy
These categories indicate the areas in which the company positions its portfolio. The company also notes that it connects patients, providers and insurers, suggesting that its offerings are integrated into coordinated care arrangements and reimbursement pathways, though specific business models or contract structures are not detailed in the available information.
Corporate evolution
In its announcement, Accendra Health reported that on December 31, 2025, it completed the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. The company also noted that its common stock would begin trading on the New York Stock Exchange under the new ticker symbol ACH effective January 2, 2026. Historical description data references the company as Owens & Minor, Inc., described as a worldwide healthcare solutions company providing products, services and technology solutions that support care delivery in hospitals, health systems and research centers.
This context indicates that Accendra Health, Inc. represents the entity following the sale of that former business and brand. The company’s current self-description emphasizes health beyond the hospital and home-based care, supported by the Apria and Byram brands, rather than the prior focus on hospital and health system supply and services referenced in older descriptions.
Role within the healthcare ecosystem
Based on the company’s statements, Accendra Health positions itself as part of the healthcare ecosystem that supports patients outside of acute care facilities. By connecting patients, providers and insurers, it aims to support care pathways for chronic and complex conditions in home and community settings. The emphasis on categories such as respiratory care, sleep health and diabetes suggests that its offerings are aligned with conditions that often require ongoing monitoring, equipment and supplies.
The company’s sector classification as wholesale-medical, dental and hospital equipment and supplies aligns with its description of providing products and related services. Its stated use of technology and services alongside products indicates an integrated approach, though specific platforms or service models are not detailed in the available information.
Ticker symbol and trading information
Accendra Health, Inc. has announced that its common stock trades on the New York Stock Exchange under the ticker symbol ACH. The change to this ticker symbol became effective after the completion of the sale of its former Products & Healthcare Services business and the Owens & Minor brand. Investors researching the symbol ACH are therefore looking at the company as it is positioned following that transaction and rebranding.
Summary
In summary, Accendra Health, Inc. (NYSE: ACH) describes itself as a nationwide provider of products, technology and services that support health beyond the hospital, with a focus on chronic and complex health conditions. The company highlights its portfolio in diabetes, sleep health, wound care, respiratory care, urology and ostomy, and notes that it connects patients, providers and insurers. Following the sale of its former Products & Healthcare Services business and the Owens & Minor brand, the company’s stock began trading under the ticker ACH on the New York Stock Exchange.
Stock Performance
Accendra Health (ACH) closed at $0.2542 on October 30, 2026. Over the past month, the price has lost 54.8%.
ACH Metrics & Rankings
Price returns through October 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Accendra Health has 10 recent news articles, with the latest published today. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, earnings date, earnings, management. View all ACH news →
SEC Filings
Accendra Health has filed 10 recent SEC filings, including 3 Form 8-K, 2 Form 4, 1 Form 144, 1 Form DEF 14A. The most recent filing was submitted on October 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ACH SEC filings →
Financial Highlights
Accendra Health generated $2.8B in revenue in FY2025, retaining a 46.7% gross margin, operating income reached $27.5M (1.0% operating margin), and net income was -$1.1B, reflecting a -39.9% net profit margin. Diluted earnings per share stood at -$14.31. The company generated -$101.8M in operating cash flow. The current ratio was 0.58, measuring current assets divided by current liabilities.
Upcoming Events
Q3 2026 Results Release
Investor Conference Call
CEO retirement
Asset sale close
Compliance cure deadline
Annual meeting anticipated
Business plan submission
Accendra Health has 7 upcoming scheduled events. The next event, "Q3 2026 Results Release", is scheduled for November 5, 2026 (in 6 days). 2 of them are earnings releases or calls. 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the ACH stock price.
Short Interest History
Short interest in Accendra Health (ACH) currently stands at 8.4 million shares, down 5.3% from the previous reporting period, representing 11.9% of the float.
Days to Cover History
Days to cover for Accendra Health (ACH) currently stands at 4.9 days, down 53.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 2.6 to 12.6 days.
ACH Company Profile & Sector Positioning
Accendra Health (ACH) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NYSE.